128 related articles for article (PubMed ID: 17033250)
1. [Two patients effectively treated by S-1 monotherapy for metastatic pancreatic cancer].
Ikeda M; Ueno H
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1515-9. PubMed ID: 17033250
[TBL] [Abstract][Full Text] [Related]
2. [Two cases of advanced pancreatic cancer with cervical lymph node or liver metastasis responding well to S-1 monotherapy].
Funakoshi A; Senju T; Sumii T
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1505-9. PubMed ID: 17033248
[TBL] [Abstract][Full Text] [Related]
3. [S-1 monotherapy for pancreatic cancer].
Okusaka T; Ueno H; Ikeda M; Morizane C
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():207-12. PubMed ID: 16898004
[TBL] [Abstract][Full Text] [Related]
4. [Resolution of liver metastases in response to S-1 monotherapy in advanced pancreatic cancer--a case report].
Mizuno N; Sawaki A; Yamao K
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1511-4. PubMed ID: 17033249
[TBL] [Abstract][Full Text] [Related]
5. [A case report of S-1 monotherapy as first-line treatment for metastatic gallbladder cancer].
Amano A; Ohkawa S; Ueno M
Gan To Kagaku Ryoho; 2007 Aug; 34(8):1307-9. PubMed ID: 17687220
[TBL] [Abstract][Full Text] [Related]
6. High response rates in patients with pancreatic cancer using the novel oral fluoropyrimidine S-1.
Hayashi K; Imaizumi T; Uchida K; Kuramochi H; Takasaki K
Oncol Rep; 2002; 9(6):1355-61. PubMed ID: 12375048
[TBL] [Abstract][Full Text] [Related]
7. Long term survival on S-1 monotherapy in a patient with recurrent stage IV pancreatic cancer.
Alsamarai S; Zergebel C; Zhang J; Furuie T; Urrea PD; Saif MW
JOP; 2008 Mar; 9(2):185-91. PubMed ID: 18326927
[TBL] [Abstract][Full Text] [Related]
8. A late phase II study of S-1 for metastatic pancreatic cancer.
Okusaka T; Funakoshi A; Furuse J; Boku N; Yamao K; Ohkawa S; Saito H
Cancer Chemother Pharmacol; 2008 Apr; 61(4):615-21. PubMed ID: 17520253
[TBL] [Abstract][Full Text] [Related]
9. [Clinical benefit of S-1 in metastatic breast cancer].
Saeki T
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():202-6. PubMed ID: 16898003
[TBL] [Abstract][Full Text] [Related]
10. [Clinical results of single therapy with TS-1 for advanced/recurrent gastric cancer].
Ohshima T; Yamada R; Hatori S; Kunisaki C; Makino T; Yamazaki Y; Suda T; Rino Y; Takanashi Y; Imada T
Gan To Kagaku Ryoho; 2006 Aug; 33(8):1105-10. PubMed ID: 16912529
[TBL] [Abstract][Full Text] [Related]
11. [Two cases of advanced extrahepatic bile duct cancer successfully treated by S-1 monotherapy].
Ueno H; Ikeda M
Gan To Kagaku Ryoho; 2007 Aug; 34(8):1311-4. PubMed ID: 17687221
[TBL] [Abstract][Full Text] [Related]
12. Phase I study of oral S-1 and concurrent radiotherapy in patients with unresectable locally advanced pancreatic cancer.
Sudo K; Yamaguchi T; Ishihara T; Nakamura K; Shirai Y; Nakagawa A; Kawakami H; Uno T; Ito H; Saisho H
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):219-24. PubMed ID: 17189072
[TBL] [Abstract][Full Text] [Related]
13. [Early phase II study of S-1 in patients with advanced head and neck cancer. S-1 Cooperative Study Group (Head and Neck Working Group)].
Inuyama Y; Kida A; Tsukuda M; Kohno N; Satake B
Gan To Kagaku Ryoho; 1998 Jul; 25(8):1151-8. PubMed ID: 9679577
[TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy-naïve advanced pancreatic cancer with multiple liver metastases successfully treated by S-1 monotherapy--a case report].
Yoshino T; Fukutomi A; Boku N
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1521-3. PubMed ID: 17033251
[TBL] [Abstract][Full Text] [Related]
15. [A late phase II clinical study of S-1 in patients with progressed, refractory breast cancer].
Saeki T; Takashima S; Sano M; Horikoshi N; Miura S; Shimizu S; Morimoto K; Kimura M; Taguchi T
Gan To Kagaku Ryoho; 2004 Apr; 31(4):539-47. PubMed ID: 15114697
[TBL] [Abstract][Full Text] [Related]
16. [Late phase II study of S-1 in patients with advanced head and neck cancer].
Inuyama Y; Kida A; Tsukuda M; Kohno N; Satake B;
Gan To Kagaku Ryoho; 2001 Oct; 28(10):1381-90. PubMed ID: 11681245
[TBL] [Abstract][Full Text] [Related]
17. [Continuous treatment with S-1, an effective strategy for an older adult with unresectable advanced pancreatic cancer with peritoneal dissemination-a case report].
Okamoto N; Inaba K; Konno H
Gan To Kagaku Ryoho; 2009 Jul; 36(7):1187-9. PubMed ID: 19620815
[TBL] [Abstract][Full Text] [Related]
18. [Successful low-dose TS-1 administration in an elderly colon cancer patient with liver metastasis].
Ohnishi T; Kanoh T; Kimura Y; Iwazawa T; Tono T; Nakano Y; Yano K; Monden T
Gan To Kagaku Ryoho; 2007 Apr; 34(4):623-5. PubMed ID: 17431353
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
Lee SJ; Cho SH; Yoon JY; Hwang JE; Bae WK; Shim HJ; Chung IJ
Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256
[TBL] [Abstract][Full Text] [Related]
20. Phase II clinical study of alternate-day oral therapy with S-1 as first-line chemotherapy for locally advanced and metastatic pancreatic cancer.
Yamaue H; Satoi S; Kanbe T; Miyazawa M; Tani M; Kawai M; Hirono S; Okada K; Yanagimoto H; Kwon AH; Mukouyama T; Tsunoda H; Chijiiwa K; Ohuchida J; Kato J; Ueda K; Yamaguchi T; Egawa S; Hayashi K; Shirasaka T
Cancer Chemother Pharmacol; 2014 Jan; 73(1):97-102. PubMed ID: 24146260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
